SPI1 activates TGF ‐β1/ PI3K /Akt signaling through transcriptional upregulation of FKBP12 to support the mesenchymal phenotype of glioma stem cells
Brain Pathology · 2024
DOI: 10.1111/bpa.13217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2024. Verfasst von Yifu Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Glioma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Liaoning BaiQianWan Talents Program, Liaoning Revitalization Talents Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Glioma stem cells (GSCs) exhibit diverse molecular subtypes with the mesenchymal (MES) population representing the most malignant variant. The oncogenic potential of Salmonella pathogenicity island 1 (SPI1), an oncogenic transcription factor, has been established across various human malignancies. In this study, we explored the association between the SPI1 pathway and the MES GSC phenotype. Through comprehensive analysis of the Cancer Genome Atlas and Chinese Glioma Genome Atlas glioma databases, along with patient‐derived GSC cultures, we analyzed SPI1 expression. Using genetic knockdown and overexpression techniques, we assessed the functional impact of SPI1 on GSC MES marker expression, invasion, proliferation, self‐renewal, and sensitivity to radiation in vitro, as well as its influence on tumor formation in vivo. Additionally, we investigated the downstream signaling cascades activated by SPI1. Our findings revealed a positive correlation between elevated SPI1 expression and the MES phenotype, which in turn, correlated with poor survival. SPI1 enhanced GSC MES differentiation, self‐renewal, and radioresistance in vitro, promoting tumorigenicity in vivo. Mechanistically, SPI1 augmented the transcriptional activity of both TGF‐β1 and FKBP12 while activating the non‐canonical PI3K/Akt pathway. Notably, inhibition of TGF‐β1/PI3K/Akt signaling partially attenuated SPI1‐induced GSC MES differentiation and its associated malignant phenotype. Collectively, our results underscore SPI1's role in activating TGF‐β1/PI3K/Akt signaling through transcriptional upregulation of FKBP12, thereby supporting the aggressive MES phenotype of GSCs. Therefore, SPI1 emerges as a potential therapeutic target in glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China.
- Department of Pathology, China Medical University, Shenyang, China.
ORCID-Profile: Sheng Han
Förderung
- Liaoning BaiQianWan Talents Program
- Liaoning Revitalization Talents Program
- National Natural Science Foundation of China
- Shenyang Young and Middle-aged Science & technology Innovation Talents Program
Zitieren
APA
Song, Y., Zhang, Y., Wang, X., Han, X., Shi, M., Xu, L., Yu, J., Zhang, L., & Han, S. (2024). SPI1 activates TGF ‐β1/ PI3K /Akt signaling through transcriptional upregulation of FKBP12 to support the mesenchymal phenotype of glioma stem cells. Brain Pathology. https://doi.org/10.1111/bpa.13217
Vancouver
Song Y, Zhang Y, Wang X, Han X, Shi M, Xu L, et al. SPI1 activates TGF ‐β1/ PI3K /Akt signaling through transcriptional upregulation of FKBP12 to support the mesenchymal phenotype of glioma stem cells. Brain Pathology. 2024. doi:10.1111/bpa.13217
BibTeX
@article{Song2024,
author = {Song, Yifu and Zhang, Yaochuan and Wang, Xiaoliang and Han, Xiaodi and Shi, Mengwu and Xu, Ling and Yu, Juanhan and Zhang, Li and Han, Sheng},
title = {SPI1 activates TGF ‐β1/ PI3K /Akt signaling through transcriptional upregulation of FKBP12 to support the mesenchymal phenotype of glioma stem cells},
journal = {Brain Pathology},
year = {2024},
doi = {10.1111/bpa.13217}
}
EUVIMED